What are the payment terms?

We accept LC, T/T, D/P, PayPal, Western Union, and small-amount payments.

What is the shelf life of the product?

The expiry date is 2 years when stored tightly sealed in a cool, dry, and dark place.

What are the contraindications for use?

Do not use in cases of severe hepatic insufficiency, osteoporosis, fracture treatment, vaccination period, or late pregnancy.

Veterinary Medicine 0.2% Dxm Injection Livestock Drug

Name: Veterinary Medicine 0.2% Dxm Injection Livestock Drug
Brand: Henan Muxiang Biological Co., Ltd.
SKU: 1949303842

Henan, ChinaHenan Muxiang Biological Co., Ltd.

Negotiable

1,000 Sets

Product profile

Customization

Available

Varieties

General Disease Prevention Medicine

Component

Chemical Synthetic Drugs

Model NO.

100ml/bottle

Type

The First Class

Pharmacodynamic Influential Factors

Combined Medication

Storage Method

Light Proof

Transport Package

Carton

Specification

50ml/bottle; 100ml/bottle

Trademark

MOOSUN

Origin

China

HS Code

3004909090

Production Capacity

50000pieces/Month

Key features

Broad Veterinary Application: Effective for horses, cattle, pigs, sheep, dogs, and cats for inflammation and allergies.

Multi-Condition Treatment: Treats ketosis, arthritis, bursitis, shock, stress, hepatitis, and allergic reactions.

Flexible Dosage Forms: Suitable for both intramuscular and intravenous administration routes.

Custom Manufacturing: OEM and ODM services available for customized veterinary drug solutions.

Manufacturer Direct: Direct from manufacturer with 360 employees and 20 R&D engineers.

Stable Quality Control: Produced in a 16,325 sqm facility with strict quality control standards.

Global Export Experience: Exports to North America, Europe, Asia, and Africa since 2016.

Fast Lead Time: Standard one-month lead time for both peak and off-season orders.

Company profile

Henan Muxiang Biological Co., Ltd.

Henan, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2016-02-01 CertifiedNearest Port: Shanghai Port, Qingdao PortAverage Response Time: ≤10.10h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryHenan Muxiang Biological Co., Ltd. is a China-based limited-company factory established in 2004, with 360 employees and operations in veterinary pharmaceuticals and animal-health products. The supplier reports seven pharmaceutical production lines, eight vaccine production lines, first-class production and inspection equipment, GMP management, ISO9001:2015 certification, and ISO/CNAS laboratory certification. Its R&D resources include more than 40 core personnel, over 30 of whom hold doctoral or master's degrees, while 21–30 quality-control staff are reported. The company exports to multiple global regions, has self-operated import and export rights, and states a one-month order-fulfillment period in both peak and off-peak seasons. Evidence supports capabilities in certification, innovation, production, and international operations. However, the provided information does not sufficiently establish after-sales service performance, financial credibility, customization execution, or specific customer cases.

Supplier typeThe supplier is identified as a limited company and a factory in the manufacturing industry, with its operating location in Henan, China. This indicates a direct manufacturing entity rather than only a trading or intermediary business.

CertificationsThe supplier reports a systematic GMP management system, ISO/CNAS laboratory international certification, and an ISO9001:2015 certificate. These stated certifications and quality systems provide explicit evidence of formal quality-management capability.

R&D capabilityThe supplier reports more than 40 core R&D personnel, including over 30 doctors or master's degree graduates, 20 years of preparation-technology experience among R&D engineers, and advanced R&D platforms such as a National Enterprise Technology Center, National Postdoctoral Research Station, and Academician Workstation. It also reports improving herbal active-ingredient extraction by more than 30% versus a traditional process, supporting a strong stated innovation profile.

Production capacityThe supplier reports seven pharmaceutical production lines and eight vaccine production lines, first-class production and inspection equipment, six production lines in a separate operational data field, and one-month order fulfillment in both peak and off-peak seasons. Although the line-count figures are not fully consistent across the slices, the evidence clearly supports substantial pharmaceutical and vaccine manufacturing capability.